Antibodies to Protease-Activated Receptor 3 Inhibit Activation of Mouse Platelets by Thrombin
Open Access
- 1 June 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 91 (11), 4152-4157
- https://doi.org/10.1182/blood.v91.11.4152
Abstract
Recent studies of mice deficient in the thrombin receptor, protease-activated receptor 1 (PAR1), provided definitive evidence for the existence of a second thrombin receptor in mouse platelets. We recently identified a new thrombin receptor designated protease-activated receptor 3 (PAR3). The mRNA encoding a mouse homologue of PAR3 was highly expressed in mouse splenic megakaryocytes, making it a good candidate for the missing mouse platelet thrombin receptor. We now report that PAR3 protein is expressed on the surface of mouse platelets and that PAR3 antibodies partially inhibit activation of mouse platelets by thrombin but not U46619, a thromboxane receptor agonist. These observations suggest that PAR3 contributes to mouse platelet activation by thrombin.Keywords
This publication has 17 references indexed in Scilit:
- Protease-activated receptor 3 is a second thrombin receptor in humansNature, 1997
- Role of the thrombin receptor in development and evidence for a second receptorNature, 1996
- Species differences in platelet responses to thrombin and SFLLRN. Receptor-mediated calcium mobilization and aggregation, and regulation by protein kinasesThrombosis Research, 1995
- Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode.Journal of Biological Chemistry, 1994
- Crystallographic Structures of Thrombin Complexed with Thrombin Receptor Peptides: Existence of Expected and Novel Binding ModesBiochemistry, 1994
- Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function.Journal of Biological Chemistry, 1992
- Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation.Journal of Clinical Investigation, 1992
- "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.Journal of Clinical Investigation, 1992
- Domains specifying thrombin–receptor interactionNature, 1991
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991